🔗 Share this article

An underground market for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Experimental Treatment Gaining Traction Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Followers are urged to contact these accounts privately for supplier links, while also obtaining promotional offers.

Thriving Trade on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with thousands of participants share “before and after” images, administration instructions and claims of next-day British shipping. Sellers promote the drug there before redirecting customers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Experts Voice Concerns

However, doctors and pharmacists have warned that the distribution of what is still an unapproved medication in the United Kingdom is worrisome and could lead to users injecting substances of unknown origin.

Several professionals said the popularity for the experimental drug could be linked to the rising cost of licensed slimming treatments such as Mounjaro.

Legal Position and Implementation

Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed medication that must not be promoted or supplied for human use under the British medical regulations.

Some influencers attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach medicines, advertising, and customer regulations, risking penalties, legal action or imprisonment.

Service Response and Material Removal

Based on the social media company, the service has removed violative content and prohibited related hashtags and search suggestions. The organization stated it was committed to maintaining the service safe and investing in enhancing compliance measures.

Online Trading Operations

Investigations also discovered communities with up to nine thousand participants marketing the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays channels with thousands of members, filled with photos of slimming results, positive testimonials and step-by-step instructions for preparing or injecting at home.

After minutes of entering one group, a seller posted contact information, where the majority of purchases occur. The seller sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about weight, health issues or past usage.

Item Information and Pricing

Inside these communities, messages show black plastic packages with postal service stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at residence with sterile water, or pre-filled injectors typically sold at £160 for 20 milligrams. When questioned how much time a pen should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Oversight and Security Actions

A representative for Telegram stated it actively moderated dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering substances they can’t verify. Although the science behind this drug is valid, these online products may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.

Her team has already seen patients injured by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet approved … may subject patients to possibly significant health risks”.